AQR Capital Management’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-27,050
| Closed | -$758K | – | 2350 |
|
|
2022
Q1 | $758K | Sell |
27,050
-2,173
| -7% | -$59.6K | ﹤0.01% | 1658 |
|
|
2021
Q4 | $798K | Hold |
29,223
| – | – | ﹤0.01% | 1658 |
|
|
2021
Q3 | $795K | Sell |
29,223
-10,861
| -27% | -$269K | ﹤0.01% | 1658 |
|
|
2021
Q2 | $685K | Buy |
40,084
+1,684
| +4% | +$31.5K | ﹤0.01% | 1760 |
|
|
2021
Q1 | $802K | Buy |
38,400
+6,716
| +21% | +$155K | ﹤0.01% | 1650 |
|
|
2020
Q4 | $726K | Sell |
31,684
-24,109
| -43% | -$459K | ﹤0.01% | 1646 |
|
|
2020
Q3 | $910K | Sell |
55,793
-78,759
| -59% | -$1.43M | ﹤0.01% | 1456 |
|
|
2020
Q2 | $1.82M | Buy |
134,552
+37,280
| +38% | +$434K | ﹤0.01% | 1198 |
|
|
2020
Q1 | $1.15M | Buy |
97,272
+66,363
| +215% | +$1.47M | ﹤0.01% | 1283 |
|
|
2019
Q4 | $770K | Buy |
30,909
+4,722
| +18% | +$95.7K | ﹤0.01% | 1600 |
|
|
2019
Q3 | $445K | Buy |
26,187
+1,259
| +5% | +$22.9K | ﹤0.01% | 1793 |
|
|
2019
Q2 | $567K | Buy |
24,928
+6,472
| +35% | +$175K | ﹤0.01% | 1693 |
|
|
2019
Q1 | $593K | Buy |
18,456
+4,255
| +30% | +$132K | ﹤0.01% | 1747 |
|
|
2018
Q4 | $400K | Sell |
14,201
-37,716
| -73% | -$1.1M | ﹤0.01% | 1865 |
|
|
2018
Q3 | $1.49M | Buy |
51,917
+8,253
| +19% | +$248K | ﹤0.01% | 1523 |
|
|
2018
Q2 | $1.64M | Buy |
43,664
+13,447
| +45% | +$528K | ﹤0.01% | 1516 |
|
|
2018
Q1 | $1.19M | Sell |
30,217
-16,606
| -35% | -$607K | ﹤0.01% | 1605 |
|
|
2017
Q4 | $1.52M | Buy |
46,823
+29,172
| +165% | +$875K | ﹤0.01% | 1500 |
|
|
2017
Q3 | $550K | Buy |
+17,651
| New | +$522K | ﹤0.01% | 1909 |
|
|
2015
Q4 | – | Sell |
-10,287
| Closed | -$241K | – | 2331 |
|
|
2015
Q3 | $241K | Buy |
+10,287
| New | +$284K | ﹤0.01% | 1999 |
|
AQR Capital Management's XENT Position: Q2 2022 in Review
AQR Capital Management sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 27,050 shares — an estimated $758K sold.
AQR Capital Management first reported a position in XENT in Q3 2015 and held it in 20 quarters. The position peaked at $1.82M in Q2 2020. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.
- AQR Capital Management reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
- AQR Capital Management sold 27,050 Intersect ENT, Inc shares in Q2 2022, an estimated $758K.
- AQR Capital Management first reported a position in Intersect ENT, Inc in Q3 2015 and held it in 20 quarters.
- AQR Capital Management's Intersect ENT, Inc position peaked at $1.82M in Q2 2020.
- 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.